Evaluation of the Effects of Post-Immediate Psychotherapeutic Interventions in Secondary Prevention of Psychotraumatic Disorders

NCT ID: NCT00455390

Last Updated: 2007-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

330 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-01-31

Study Completion Date

2009-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Argumentation The frequency of post-traumatic syndrome disorder (PTSD) is estimated around 1% of the entire European population. In some specific populations, this percentage increases (soldiers - 15 to 22%, war or persecuted refugees - 80%, post office or bank employees submitted to an hold-up - 17%, firemen - 10 to 30%, emergency care employees - 11%, people who underwent a terrorist attack or any violence - 20 to 65%...)

Prevention is yet poor, secondary prevention trying to avoid a post traumatic disorder apparition early after the traumatic event. There is currently two types of secondary prevention :

* Mitchell's debriefing based upon stress and its theories, using cognitive and behavioural approaches
* French debriefing (post-immediate psychotherapeutic intervention) based on the traumatism, never realised before second day post event and applied by mental health professionals.

The current controversy of the Mitchell's debriefing leads us to evaluate the post-immediate psychotherapeutic intervention, never evaluated yet.

Scientific Objectives Primary objective: To verify that post-immediate psychotherapeutic interventions (proposed after 2 days and before the end of first month post event) decrease incidence, duration and intensity of psychotraumatic disorders at one year, versus a control group.

Secondary objectives :

* To document the efficacy of these interventions regarding professional, social and familial adaptation.
* To identify predictive factors of response to this strategy.

Method Experimental Design National multicentered, randomized, single blind study Study Population 330 men or women aged 18 to 65, subjected to a potentially traumatic event (criteria A1, DSM IV) and having presented an emotional reaction (intense fear, impotency or horror, criteria A2, DSM IV). This event must have happened within 8 days prior randomization. Patients treated with βblockers and patients suffering from psychopathologic disorders won't be considered for the study.

Outcome measures Primary outcome: PTSD frequency (on the basis of questionnaire CAPS).

Secondary outcome:

* Complete and subsyndormic PTSD occurence (CAPS),
* Intensity of psychotraumatic disorders (Sheehan scale),
* Psychopathologic disorder frequency (CIDI SF),
* Evolution of anxiety/depression (HAD scale),
* Alcoholization frequency (CAGE scale),
* Frequency of somatic adverse events,
* Access to health care (number and types of contacts).

Expected benefits The post-immediate psychotherapeutic intervention shall avoid psychological disorders apparition or improve its symptoms. This would decrease consequences on personal life (social, relational and professional).

The study results will allow a better knowledge of these post traumatic disorders.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Intervention:

Group 1: Post-immediate psychotherapeutic intervention, 2 to 3 seances within the first month following the potentially traumatic event. Each intervention last about 45 minutes.

Group 2-control: no psychotherapeutic intervention, only 2 to 3 supporting sessions.

Eligibility criteria:

Inclusion criteria

* men or women aged 18 to 65,
* subjected to a potentially traumatic event (criteria A1, DSM IV),
* having presented an emotional reaction (intense fear, impotency or horror, criteria A2, DSM IV),
* potentially traumatic event happening within 8 days prior randomization.

Non inclusion criteria

* patients treated with βblockers ,
* patients suffering from psychopathologic disorders within 15 days prior randomization (Axe I DSM IV),
* physical injuries avoiding patient's participation to the study,
* hospitalization \> 72 hours post event,
* traumatic event related to a process of victimisation (domestic violences),
* no informed consent signed

Study type:

Randomized, single blind trial on two parallel groups. Randomization stratified on sex and human design.

Number of patients:

330 in 18 clinical centres

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PTSD Post Traumatic Syndrome Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Post-immediate Psychotherapeutic Intervention

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* men or women aged 18 to 65,
* subjected to a potentially traumatic event (criteria A1, DSM IV),
* having presented an emotional reaction (intense fear, impotency or horror, criteria A2, DSM IV),
* potentially traumatic event happening within 8 days prior randomization.

Exclusion Criteria

* patients treated with βblockers ,
* patients suffering from psychopathologic disorders within 15 days prior randomization (Axe I DSM IV),
* physical injuries avoiding patient's participation to the study,
* hospitalization \> 72 hours post event,
* traumatic event related to a process of victimisation (domestic violences),
* no informed consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Groupe Francais d'Epidemiologie Psychiatrique

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nathalie PRIETO, MDH

Role: PRINCIPAL_INVESTIGATOR

Hospices Civils de Lyon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Edouard Herriot - SAMU

Lyon, Auvergne-Rhône-Alpes, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jean-Pierre VIGNAT, MDH

Role: CONTACT

+33 4 37 90 11 75

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nathalie PRIETO, MDH

Role: primary

+33 4 72 11 63 87

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IPPI A

Identifier Type: -

Identifier Source: org_study_id